Blog Posts
Quick filters:
Found 3 results for "Biotech"
The Profitability Pivot: Why Iām Betting on These 3 Oncology Outliers
Thu, Feb 5, 2026
Iām moving away from speculative biotech and focusing on these three oncology stocks with real revenue and upcoming 2026 catalysts.
My 2026 Watchlist: 3 Asymmetric Trades for the M&A Supercycle
Wed, Dec 17, 2025
Big Pharma faces a $200B revenue hole in 2026. Here are the 3 cash-rich, commercial-stage stocks I'm tracking to play the coming M&A wave.
3 Asymmetric Stocks Hiding in Plain Sight (December 2025)
Wed, Nov 19, 2025
The oncology sector is waking up. Here are 3 high-conviction stocks I'm watching before the major December conferences shake up the market.
